Patent · US Active

Mono- or di-substituted indoles as dengue viral replication inhibitors

US10206902B2 · kind B2 · utility

14Cited by

0References

9Claims

0Family size

Assignees

Janssen Pharmaceuticals, Inc. · BE
Katholieke Universiteit Leuven · BE

Inventors

Bart Rudolf Romanie Kesteleyn · Berlare, BE
Jean-François Bonfanti · Andé, FR
Tim Hugo Maria Jonckers · Heist-op-den-Berg, BE
Pierre Jean-Marie Bernard Raboisson · Sligo, IE
Dorothée Alice Marie-Eve Bardiot · Leuven, BE
Arnaud Marchand · Leuven, BE

Key dates

Filing date	Sep 30, 2015
Grant date	Feb 19, 2019
Priority date	—
Expiry date	Sep 30, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention concerns mono- or di-substituted indole compounds of formula (I) which are useful to prevent or treat dengue viral infections and also relates to said compounds for use as a medicine, more preferably for use as a medicine to treat or prevent dengue viral infections. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the compounds, to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of dengue viral infections. The invention also relates to processes for preparation of the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.